Start-Up Previews (10/06)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Women's Health: A Growing Market for Diagnostic Players, includes profiles of Diamics, Onconix, RCP Diagnostics and Valeo Medical. Plus these Start-Ups Across Health Care: Corindus, Gynesonics, NovaSterilis and Zogenix.
You may also be interested in...
Coronavirus Notebook: Heterologous Vaccine Study Shows Positive Results, UK Offers Earlier Second Dose To Vulnerable People
The European Medicines Agency has extended the time that Cominarty can spend in a fridge after defrosting and could this week issue advice to member states on sotrovimab for use in COVID-19 patients. Norway’s BerGenBio has published top-line data from a Phase II trial of of bemcentinib, and IcanoMAB has outlined the potential of its anti-IL-1R7 antibody.
Myovant, Bayer and Rhythm Pharmaceuticals are among the companies that could soon learn whether the European Medicines Agency thinks their drugs are fit for approval.
The umbrella organization for public insurers is also expected to publish its own suggestions on how to cut spending on pharmaceuticals, including interim prices for conditionally approved drugs.